Cargando…
The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
BACKGROUND: The impact of cerebral microbleeds on the safety of antithrombotic therapy has recently received considerable attention. We investigated the safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism caused by nonvalvular atrial fibrillation....
Autores principales: | Wang, Jiayu, Zhang, Jia, Shen, Yuan, Xu, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444618/ https://www.ncbi.nlm.nih.gov/pubmed/30940095 http://dx.doi.org/10.1186/s12872-019-1046-y |
Ejemplares similares
-
Early neurological deterioration in cardiogenic cerebral embolism due to nonvalvular atrial fibrillation: Predisposing factors and clinical implications
por: Cong, Lin, et al.
Publicado: (2020) -
Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease
por: Cheng, Yajun, et al.
Publicado: (2019) -
Cerebral Microbleeds With Atrial Fibrillation After Ablation Therapy
por: Hirata, Yoshinori, et al.
Publicado: (2022) -
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
por: Mostaza, Jose María, et al.
Publicado: (2021) -
Clinical and Imaging Characteristics of Cerebral Infarction in Patients with Nonvalvular Atrial Fibrillation Combined with Cerebral Artery Stenosis
por: Sun, Wei, et al.
Publicado: (2018)